In-vitro Diagnostics Market to Hit 92 Billion By 2024 Profiling Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher & more

MarketStudyReport.com Adds New In-vitro Diagnostics Market 2018 – 2024 research report providing information and data By Type, By Technology, By Application, By End-User, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast spreading across 350 Pages with table and figures in it.

Hospitals segment of in-vitro diagnostics market held largest revenue share of 30.6% and should expand significantly in the coming years due to increasing number of hospital admissions demanding critical monitoring and accurate diagnosis. According to Statista hospital care expenditures in 2017, was around USD 1,132.6 billion in the U.S. indicating strong demand for in-vitro diagnostics in the upcoming years.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1230579/

Molecular diagnostics segment accounted for 16.2% revenue share in 2017 and growth can be accounted to high cases of diabetes and other chronic infections that demand critical monitoring. According to International Diabetes Federation in 2017, there were around 7.4 million cases of diabetes in Germany that will increase the demand in upcoming years.

In-vitro diagnostics market should witness considerable growth over the forecast timeframe owing to the growing awareness amongst patients regarding the availability of diagnostic tests. Technology integrated within these devices will improve efficiency of diagnostic devices proving beneficial for the industry growth. Various American organizations such as Center for Chronic Disease Control have implemented certain initiatives that will increase awareness levels for availability of technologically advanced diagnostics among the people that should impact positively in-vitro diagnostics market growth in the upcoming future.

U.S. in-vitro diagnostics market valued at USD 23.9 billion in 2017 and is expected to grow exponentially over the forecast timeframe. According to CDC, around 40% of the Americans expire due to chronic diseases that will enhance industry growth. Moreover, development of favorable reimbursement scenario will drive the business growth significantly.

Oncology segment held USD 12.6 billion in 2017 as a result of rising cases of cancer globally. Additionally, growing prevalence of cancer in developing countries such as India will increase the demand for molecular diagnostic reagents and devices. In India, there are around 1.4 million cases of cancer every year that will boost segmental growth over the forecast timeframe.

Reagents and kits segment held largest market share of 67.7% in 2017 as a result of high prevalence of rare diseases that will have a positive impact on segmental growth. Escalating usage of molecular reagents for detection of various diseases such as Morgellons, Adie syndrome and Crohn disease will boost industry growth over the forecast timeframe. Moreover, key industry players such as Bio-Rad, Beckman Coulter and Cambio emphasize on manufacturing superior quality reagents that aid accurate diagnosis thereby, fosters in-vitro diagnostics industry growth over the forecast timeframe.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1230579/

Some of the prominent industry players operating in in-vitro diagnostics industry is Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. Strategic initiatives such as new product launch, mergers & acquisition will aid revenue generation for the company. For instance, in April 2017, Abbott declared acquisition of Alere that has enabled Abbott?s point-of-care testing product portfolio that will help Abbott to maintain its market position.

Table of Content:

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. In-vitro diagnostics industry 360 degree synopsis, 2013 - 2024

2.1.1. Business trends

2.1.2. Type trends

2.1.3. Technology trends

2.1.4. Application trends

2.1.5. End-user trends

2.1.6. Regional trends

Chapter 3. In-vitro Diagnostics Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2013 - 2024

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing rate of healthcare infections particularly in North America

3.3.1.2. Increasing adoption rate of automated diagnostic machine & equipment in Europe

3.3.1.3. Rising geriatric population preferring personalized medicines in Asia Pacific

3.3.1.4. Surging number of pathology labs and services equipped with advanced diagnostics machine

3.3.1.5. Increasing awareness regarding viral disease detection in the U.S.

3.3.2. Industry pitfalls and challenges

3.3.2.1. Excessive cost of diagnosis service

3.4. Growth potential analysis

3.4.1. By type

3.4.2. By technology

3.4.3. By application

3.4.4. By end-user

3.5. Regulatory landscape

3.5.1. U.S.

3.5.2. Europe

3.6. Porter's analysis

3.7. Competitive landscape, 2017

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. In-vitro Diagnostics Market, By Type

4.1. Key segment trends

4.2. Product

4.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.2. Reagents & kits

4.2.2.1. Market size, by region, 2013-2024 (USD Million)

4.2.3. Instruments

4.2.3.1. Market size, by region, 2013-2024 (USD Million)

4.3. Service

4.3.1. Market size, by region, 2013-2024 (USD Million)

4.3.2. Software

4.3.2.1. Market size, by region, 2013-2024 (USD Million)

4.3.3. Testing services

4.3.3.1. Market size, by region, 2013-2024 (USD Million)

Chapter 5. In-vitro Diagnostics Market, By Technology

5.1. Key segment trend

5.2. Clinical chemistry

5.2.1. Market size, by region, 2013-2024 (USD Million)

5.3. Immunoassay/immunochemistry

5.3.1. Market size, by region, 2013-2024 (USD Million)

5.4. Molecular diagnostics

5.4.1. Market size, by region, 2013-2024 (USD Million)

5.5. Hematology

5.5.1. Market size, by region, 2013-2024 (USD Million)

5.6. Microbiology

5.6.1. Market size, by region, 2013-2024 (USD Million)

5.7. Coagulation and hemostasis

Market size, by region, 2013-2024 (USD Million)

5.8. Urinalysis

Market size, by region, 2013-2024 (USD Million)

5.9. Others

Market size, by region, 2013-2024 (USD Million)

Chapter 6. In-vitro Diagnostics Market, By Application

6.1. Key segment trend

6.2. Oncology

6.2.1. Market size, by region, 2013-2024 (USD Million)

6.3. Infectious diseases

6.3.1. Market size, by region, 2013-2024 (USD Million)

6.4. Diabetes

6.4.1. Market size, by region, 2013-2024 (USD Million)

6.5. Cardiology

6.5.1. Market size, by region, 2013-2024 (USD Million)

6.6. Nephrology

6.6.1. Market size, by region, 2013-2024 (USD Million)

6.7. Autoimmune diseases

6.7.1. Market size, by region, 2013-2024 (USD Million)

6.8. Drug testing/pharmacogenomics

6.8.1. Market size, by region, 2013-2024 (USD Million)

6.9. Others

6.9.1. Market size, by region, 2013-2024 (USD Million)

Chapter 7. In-vitro Diagnostics Market, By End-user

7.1. Key segment trend

7.2. Hospitals

7.2.1. Market size, by region, 2013-2024 (USD Million)

7.3. Point of care

7.3.1. Market size, by region, 2013-2024 (USD Million)

7.4. Laboratories

7.4.1. Market size, by region, 2013-2024 (USD Million)

7.5. Academic institutes

7.5.1. Market size, by region, 2013-2024 (USD Million)

7.6. Others

7.6.1. Market size, by region, 2013-2024 (USD Million)

Chapter 8. In-vitro Diagnostics Market, By Region

Chapter 9. In-vitro Diagnostics Market Company Profiles

More Report At: https://www.marketstudyreport.com/reports/in-vitro-diagnostics-market

Related Report:

Global In-vitro Diagnostics Market Growth (Status and Outlook) 2018-2023
This report presents a comprehensive overview, market shares and growth opportunities of In-vitro Diagnostics market by product type, application, key companies and key regions. In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections. Pregnancy tests and checks of blood glucose levels are two examples of IVDs. High prevalence of chronic and infectious diseases, increasing use of point of care (POC) diagnostics, and surging number of private hospitals and independent testing laboratories are some of the other factors contributing to the growth of the market.

https://www.marketstudyreport.com/reports/global-in-vitro-diagnostics-market-growth-status-and-outlook-2018-2023

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.